Literature DB >> 23561746

Improvement of pathology in sub-Saharan Africa.

Adekunle Adesina1, David Chumba, Ann M Nelson, Jackson Orem, Drucilla J Roberts, Henry Wabinga, Michael Wilson, Timothy R Rebbeck.   

Abstract

In the coming decades, cancer will be a major clinical and public health issue in sub-Saharan Africa. However, clinical and public health infrastructure and services in many countries are not positioned to deal with the growing cancer burden. Pathology is a core service required to serve many needs related to cancer in sub-Saharan Africa. Cancer diagnosis, treatment, and research all depend on adequate pathology. Pathology is also necessary for cancer registration, which is needed to accurately estimate cancer incidence and mortality. Cancer registry data directly guide policy-makers' decisions for cancer control and the allocation of clinical and public health services. Despite the centrality of pathology in many components of cancer care and control, countries in sub-Saharan Africa have at best a tenth of the pathology coverage of that in high-income countries. Equipment, processes, and services are lacking, and there is a need for quality assurance for the definition and implementation of high-quality, accurate diagnosis. Training and advocacy for pathology are also needed. We propose approaches to improve the status of pathology in sub-Saharan Africa to address the needs of patients with cancer and other diseases.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23561746     DOI: 10.1016/S1470-2045(12)70598-3

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  97 in total

1.  The incidence of oesophageal cancer in Eastern Africa: identification of a new geographic hot spot?

Authors:  Michael L Cheng; Li Zhang; Margaret Borok; Eric Chokunonga; Charles Dzamamala; Anne Korir; Henry R Wabinga; Robert A Hiatt; D Max Parkin; Katherine Van Loon
Journal:  Cancer Epidemiol       Date:  2015-02-03       Impact factor: 2.984

2.  Plasma Epstein-Barr virus DNA for pediatric Burkitt lymphoma diagnosis, prognosis and response assessment in Malawi.

Authors:  Katherine D Westmoreland; Nathan D Montgomery; Christopher C Stanley; Nader Kim El-Mallawany; Peter Wasswa; Toon van der Gronde; Idah Mtete; Mercy Butia; Salama Itimu; Mary Chasela; Mary Mtunda; Coxcilly Kampani; N George Liomba; Tamiwe Tomoka; Bal M Dhungel; Marcia K Sanders; Robert Krysiak; Peter Kazembe; Dirk P Dittmer; Yuri Fedoriw; Satish Gopal
Journal:  Int J Cancer       Date:  2017-03-24       Impact factor: 7.396

3.  Quantitative analysis of high-resolution microendoscopic images for diagnosis of esophageal squamous cell carcinoma.

Authors:  Dongsuk Shin; Marion-Anna Protano; Alexandros D Polydorides; Sanford M Dawsey; Mark C Pierce; Michelle Kang Kim; Richard A Schwarz; Timothy Quang; Neil Parikh; Manoop S Bhutani; Fan Zhang; Guiqi Wang; Liyan Xue; Xueshan Wang; Hong Xu; Sharmila Anandasabapathy; Rebecca R Richards-Kortum
Journal:  Clin Gastroenterol Hepatol       Date:  2014-07-25       Impact factor: 11.382

4.  Automated frame selection process for high-resolution microendoscopy.

Authors:  Ayumu Ishijima; Richard A Schwarz; Dongsuk Shin; Sharon Mondrik; Nadarajah Vigneswaran; Ann M Gillenwater; Sharmila Anandasabapathy; Rebecca Richards-Kortum
Journal:  J Biomed Opt       Date:  2015-04       Impact factor: 3.170

5.  Cervical cancer risk and impact of Pap-based screening in HIV-positive women on antiretroviral therapy in Johannesburg, South Africa.

Authors:  Eliane Rohner; Mazvita Sengayi; Bridgette Goeieman; Pamela Michelow; Cynthia Firnhaber; Mhairi Maskew; Julia Bohlius
Journal:  Int J Cancer       Date:  2017-05-19       Impact factor: 7.396

Review 6.  High-quality health systems in the Sustainable Development Goals era: time for a revolution.

Authors:  Margaret E Kruk; Anna D Gage; Catherine Arsenault; Keely Jordan; Hannah H Leslie; Sanam Roder-DeWan; Olusoji Adeyi; Pierre Barker; Bernadette Daelmans; Svetlana V Doubova; Mike English; Ezequiel García-Elorrio; Frederico Guanais; Oye Gureje; Lisa R Hirschhorn; Lixin Jiang; Edward Kelley; Ephrem Tekle Lemango; Jerker Liljestrand; Address Malata; Tanya Marchant; Malebona Precious Matsoso; John G Meara; Manoj Mohanan; Youssoupha Ndiaye; Ole F Norheim; K Srinath Reddy; Alexander K Rowe; Joshua A Salomon; Gagan Thapa; Nana A Y Twum-Danso; Muhammad Pate
Journal:  Lancet Glob Health       Date:  2018-09-05       Impact factor: 26.763

Review 7.  Challenges in the detection, prevention, and treatment of HIV-associated malignancies in low- and middle-income countries in Africa.

Authors:  Clement A Adebamowo; Corey Casper; Kishor Bhatia; Sam M Mbulaiteye; Annie J Sasco; Warren Phipps; Sten H Vermund; Susan E Krown
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

8.  The Role of Affordable, Point-of-Care Technologies for Cancer Care in Low- and Middle-Income Countries: A Review and Commentary.

Authors:  Karen Haney; Pushpa Tandon; Rao Divi; Miguel R Ossandon; Houston Baker; Paul C Pearlman
Journal:  IEEE J Transl Eng Health Med       Date:  2017-11-23       Impact factor: 3.316

9.  A Comparison of the Natural History of HPV Infection and Cervical Abnormalities among HIV-Positive and HIV-Negative Women in Senegal, Africa.

Authors:  Hilary K Whitham; Stephen E Hawes; Haitao Chu; J Michael Oakes; Alan R Lifson; Nancy B Kiviat; Papa Salif Sow; Geoffrey S Gottlieb; Selly Ba; Marie P Sy; Shalini L Kulasingam
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-05-17       Impact factor: 4.254

10.  Task Shifting and Skin Punch for the Histologic Diagnosis of Kaposi's Sarcoma in Sub-Saharan Africa: A Public Health Solution to a Public Health Problem.

Authors:  Miriam O Laker-Oketta; Megan Wenger; Aggrey Semeere; Barbara Castelnuovo; Andrew Kambugu; Robert Lukande; F Chite Asirwa; Naftali Busakhala; Nathan Buziba; Lameck Diero; Kara Wools-Kaloustian; Robert Matthew Strother; Mwebesa Bwana; Winnie Muyindike; Erin Amerson; Edward Mbidde; Toby Maurer; Jeffrey Martin
Journal:  Oncology       Date:  2015-02-27       Impact factor: 2.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.